A case of abiraterone acetate withdrawal syndrome after initiation of upfront abiraterone therapy for high‐risk prostate cancer

INTRODUCTION: Transient decrease in serum prostate‐specific antigen level can occur after abiraterone acetate withdrawal in male patient with metastatic castration‐resistant prostate cancer. Here, we report a case of abiraterone acetate withdrawal syndrome with transient prostate‐specific antigen de...

Descripción completa

Detalles Bibliográficos
Autores principales: Tani, Masaru, Hayashi, Yujiro, Miki, Airi, Wakita, Teppei, Horibe, Yuki, Kakuta, Yoichi, Tsutahara, Koichi, Takao, Tetsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475332/
https://www.ncbi.nlm.nih.gov/pubmed/37667762
http://dx.doi.org/10.1002/iju5.12604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475332/
https://www.ncbi.nlm.nih.gov/pubmed/37667762
http://dx.doi.org/10.1002/iju5.12604

Ejemplares similares